Cargando…
2-Methoxyestradiol as an Antiproliferative Agent for Long-Term Estrogen-Deprived Breast Cancer Cells
To identify effective treatment modalities for breast cancer with acquired resistance, we first compared the responsiveness of estrogen receptor-positive breast cancer MCF-7 cells and long-term estrogen-deprived (LTED) cells (a cell model of endocrine therapy-resistant breast cancer) derived from MC...
Autores principales: | Hirao-Suzuki, Masayo, Kanameda, Koki, Takiguchi, Masufumi, Sugihara, Narumi, Takeda, Shuso |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10527823/ https://www.ncbi.nlm.nih.gov/pubmed/37754248 http://dx.doi.org/10.3390/cimb45090464 |
Ejemplares similares
-
(–)-Xanthatin as a Killer of Human Breast Cancer MCF-7 Mammosphere Cells: A Comparative Study with Salinomycin
por: Takeda, Shuso, et al.
Publicado: (2022) -
The Bone Sparing Effects of 2-Methoxyestradiol Are Mediated via Estrogen Receptor-α in Male Mice
por: Eriksson, Anna L., et al.
Publicado: (2016) -
Estrogen Receptor Complex to Trigger or Delay Estrogen-Induced Apoptosis in Long-Term Estrogen Deprived Breast Cancer
por: Maximov, Philipp Y., et al.
Publicado: (2022) -
Estrogen Metabolite 2-Methoxyestradiol Attenuates Blood Pressure in Hypertensive Rats by Downregulating Angiotensin Type 1 Receptor
por: Zhang, Yong, et al.
Publicado: (2022) -
Mechanisms underlying differential response to estrogen-induced apoptosis in long-term estrogen-deprived breast cancer cells
por: SWEENEY, ELIZABETH E., et al.
Publicado: (2014)